Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis.


Journal

BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291

Informations de publication

Date de publication:
10 Jul 2023
Historique:
pmc-release: 10 07 2025
medline: 12 7 2023
pubmed: 11 7 2023
entrez: 10 7 2023
Statut: epublish

Résumé

Drug-induced vasculitis can rarely cause inflammation and necrosis of blood vessel walls of both kidney and lung tissue. Diagnosis is challenging because of the lack of difference between systemic and drug-induced vasculitis in clinical presentation, immunological workup and pathological findings. Tissue biopsy guides diagnosis and treatment. Pathological findings must be correlated with clinical information to arrive at a presumed diagnosis of drug-induced vasculitis. We present a patient with hydralazine-induced antineutrophil cytoplasmic antibodies-positive vasculitis with a pulmonary-renal syndrome manifesting as pauci-immune glomerulonephritis and alveolar haemorrhage.

Identifiants

pubmed: 37429646
pii: 16/7/e254736
doi: 10.1136/bcr-2023-254736
pmc: PMC10335510
pii:
doi:

Substances chimiques

Hydralazine 26NAK24LS8
Antibodies, Antineutrophil Cytoplasmic 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Indira Acharya (I)

Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA.

David S Weisman (DS)

Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA david.s.weisman@medstar.net.

Lanaya Williams Smith (LW)

Department of Internal Medicine, MedStar Good Samaritan Hospital, Baltimore, Maryland, USA.

Lois Johanna Arend (LJ)

Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH